Showing Results for
- Academic Journals (3,401)
Search Results
- 3,401
Academic Journals
- 3,401
-
From:Oncology (Vol. 28, Issue 9) Peer-ReviewedSince the late 1890s, when morphologic tumor heterogeneity was first described by pathologists, tumor heterogeneity has been recognized as an important and relevant clinical problem. From the discovery of tumor...
-
From:Future Oncology (Vol. 10, Issue 10) Peer-ReviewedAuthor(s): Carolin Bock aff1 , Brigitte Rack aff1 , Jens Huober aff2 , Ulrich Andergassen aff1 , Udo Jeschke aff1 , Sophie Doisneau-Sixou [*] aff3 KEYWORDS breast cancer; CD133; circulating tumor cells; EMT;...
-
From:Phytomedicine: International Journal of Phytotherapy & Phytopharmacology (Vol. 22, Issue 2) Peer-ReviewedABSTRACT Purpose: Efficient strategies for the prevention of colon cancer are extensively being explored, including dietary intervention and the development of novel phytopharmaceuticals. Safe extracts of edible...
-
From:Journal of the Mississippi Academy of Sciences (Vol. 60)There is less than a thirty percent survival rate for patients with a localized pancreatic tumor, and less than a ten percent survival rate for patients with metastases. There are diverse findings on the...
-
From:Future Oncology (Vol. 8, Issue 10) Peer-ReviewedAuthor(s): James Ho CS 1 , Anna Rydström 1 , Maria Trulsson 1 , Johannes Bålfors 1 , Petter Storm 1 , Manoj Puthia 1 , Aftab Nadeem 1 , Catharina Svanborg [*] 2 Keywords * clinical studies; conserved death...
-
From:Gene Therapy (Vol. 15, Issue 23) Peer-ReviewedGene Therapy (2008) 15, 1511-1512; doi:10.1038/gt.2008.139; published online 21 August 2008 Finding cells that genuinely traffic to tumors has not been straightforward. Many have been tried, including T cells, (1,2)...
-
From:Pharmaceutical Technology Europe (Vol. 20, Issue 12) Peer-ReviewedScientists have discovered the two key processes that allow cancer cells to change the way they move to spread through the body, according to the journal Cell. "The spreading of cancer cells from one part of the body...
-
From:Integrative Cancer Therapies (Vol. 5, Issue 4) Peer-ReviewedBackground: Increasing evidence suggests that the inability to undergo apoptosis is an important factor in the development and progression of prostate cancer. Agents that induce apoptosis may inhibit tumor growth and...
-
From:Family Practice News (Vol. 29, Issue 10)MIAMI -- The oral diabetes drug troglitazone appears to convert malignant liposarcoma cells into more normal cells and may open up a new avenue of investigation for anticancer drug development, Dr. George D. Demetri...
-
From:Indian Journal of Cancer (Vol. 52, Issue 7) Peer-ReviewedByline: L. Yi, Y. Yuan OBJECTIVE: MicroRNAs (miRNAs) were popularly investigated in many cancers. The aim of this study was to evaluate the expression, role, and mechanism of microRNA-618 (miR-618) in human thyroid...
-
From:Journal of Experimental & Clinical Cancer Research (Vol. 28) Peer-ReviewedAuthors: Eva Henriksson (corresponding author) [1]; Elisabeth Kjellén [2]; Bo Baldetorp [2]; Pär-Ola Bendahl [2]; Åke Borg [2]; Eva Brun [2]; Fredrik Mertens [3]; Tomas Ohlsson [4]; Karin Rennstam [2]; Johan Wennerberg...
-
From:PLoS ONE (Vol. 7, Issue 12) Peer-ReviewedAuthor(s): Peihua Ni 1 , 2 , Hong Xu 3 , Changqiang Chen 2 , Jiayi Wang 2 , Xiangfan Liu 2 , Yiqun Hu 2 , Qishi Fan 2 , Zhaoyuan Hou 3 , * , Yang Lu 1 , * Introduction Inactivation of cell-death pathways is a...
-
From:PLoS ONE (Vol. 8, Issue 3) Peer-ReviewedAuthor(s): Mourad W. Ali 1 , Ercan Cacan 2 , Yuying Liu 3 , Jennifer Young Pierce 4 , 5 , William T. Creasman 4 , 5 , Mandi M. Murph 1 , Rajgopal Govindarajan 1 , Scott T. Eblen 3 , 5 , Susanna F. Greer 2 , Shelley B....
-
From:Nature (Vol. 549, Issue 7670) Peer-ReviewedAuthor(s): Marian L. Burr (corresponding author) [1, 2, 3]; Christina E. Sparbier [1]; Yih-Chih Chan [1]; James C. Williamson [3]; Katherine Woods [4, 5]; Paul A. Beavis [1, 2]; Enid Y. N. Lam [1, 2]; Melissa A....
-
From:Proceedings of the North Dakota Academy of Science (Vol. 71) Peer-ReviewedEnhancers are regulatory regions of DNA that play significant roles in determining the fate of a cell. Enhancers can be present in active or inactive state in a cell and these states can directly affect gene expression....
-
From:CytoJournal (Vol. 14, Issue 1) Peer-ReviewedByline: Jeanine. Chiaffarano, Melissa. Alexander, Robert. Rogers, Fang. Zhou, Joan. Cangiarella, Melissa. Yee-Chang, Paul. Elgert, Aylin. Simsir Background: The Bethesda System uses a two-tiered approach in the...
-
From:BioMed Research InternationalPeer-ReviewedCombination therapy of bortezomib with other chemotherapeutics is an emerging treatment strategy. Since both curcumin and bortezomib inhibit NF-[kappa]B, we tested the effects of their combination on leukemia cells. To...
-
From:BioMed Research InternationalPeer-ReviewedTriple-negative breast cancer (TNBC) is an aggressive type of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (Her2/neu). TNBC has worse...
-
From:BioMed Research InternationalPeer-ReviewedGarcinia dulcis or locally known in Malaysia as "mundu" belongs to the family of Clusiaceae. The study was conducted to investigate the anticancer potential of different parts of G. dulcis fruit extracts and their...
-
From:BioMed Research InternationalPeer-ReviewedBreast cancer is the leading cause of cancer-related deaths among women in the United States, and survival rates are lower for patients with metastases and/or triple-negative breast cancer (TNBC; ER, PR, and Her2...